All news
DiCE Member Codice Viola Helps Shift to Multidisciplinary Pancreatic Cancer Care
27 April 2022DiCE Member Codice Viola helps in the shift towards specialised pancreatic cancer care units in the Italian Lombardy Region
...Promising Research Published for Early Detection of a Certain Pancreatic Cancer
26 April 2022Study published in ‘Gut’ finds new molecular signature that could help in identifying most common form of pancreatic cancer – PDA...
DiCE CRC Biomarkers Project Moves Ahead -Thanks to the Members that Participated!
26 April 2022Thanks to the help and input of our member organisations the DiCE project for education on CRC biormarkers advances towards delivery
...DiCE Participates in Global Colorectal Cancer Congress
20 April 2022DiCE CEO Zorana Maravic participates in the 2022 CRC Congress adding the European digestive cancer patient voice to this global event
...Welcome to Our New Italian Member – Codice Viola
22 March 2022We are very pleased to give a warm and hearty welcome to Codice Viola into our Digestive Cancers Europe network of Members.
...Raising Awareness for Rare Cancers – Anal Cancer Awareness Day March 21
18 March 2022Anal cancer is a rare cancer on the rise. In the EU 9.249 men and women were newly diagnosed with this cancer, in 2020
...March 22 is Lynch Syndrome Awareness Day
18 March 2022Lynch Syndrome is the most common inherited cancer syndrome in the world, with an estimation of 1 in 370 people carrying the genetic mutation.
...DiCE Materials Accessible in European Languages
18 March 2022Digestive Cancers Europe Makes Materials Accessible in European Languages
...EMA approves two combination-treatments for an aggressive oesophageal cancer
18 March 2022EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cel...
New Reports Support Improved Cancer Screening Programmes in Europe
9 March 2022Two new reports provide recommendations on digestive cancer screening to the European Commission
...